The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Classic and New Animal Models of Parkinson's Disease
Open accessAbstract
Neurological disorders can be modeled in animals so as to recreate specific pathogenic events and behavioral outcomes. Parkinson’s Disease (PD) is the second most common neurodegenerative disease of an aging population, and although there have been several significant findings about the PD disease process, much of this process still remains a mystery. Breakthroughs in the last two decades using animal models have offered insights into the understanding of the PD disease process, its etiology, pathology, and molecular mechanisms. Furthermore, while cellular models have helped to identify specific events, animal models, both toxic and genetic, have replicated almost all of the hallmarks of PD and are useful for testing new neuroprotective or neurorestorative strategies. Moreover, significant advances in the modeling of additional PD features have come to light in both classic and newer models. In this review, we try to provide an updated summary of the main characteristics of these models as well as the strengths and weaknesses of what we believe to be the most popular PD animal models. These models include those produced by 6-hydroxydopamine (6-OHDA), 1-methyl-1,2,3,6-tetrahydropiridine (MPTP), rotenone, and paraquat, as well as several genetic models like those related to alpha-synuclein, PINK1, Parkin and LRRK2 alterations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Self-citationChronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
A Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118
Lees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
Reversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus
Bergman, H., Wichmann, T., & DeLong, M. R. (1990) · Science · doi:10.1126/science.2402638 · Cited by 1,907
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
Rotenone, Paraquat, and Parkinson’s Disease
Tanner, C. M., Kamel, F., Ross, G. W., Hoppin, J. A., Goldman, S. M., Korell, M., Marras, C., Bhudhikanok, G. S., Kasten, M., Chade, A. R., et al. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002839 · Cited by 1,475
Neuropathology of Parkinsonʼs Disease
Forno, L. S. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,465
6-hydroxy-dopamine induced degeneration of central monoamine neurons
Ungerstedt, U. (1968) · European Journal of Pharmacology · doi:10.1016/0014-2999(68)90164-7 · Cited by 1,460
Ungerstedt, U. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.1971.tb11001.x · Cited by 1,290
3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists
CARLSSON, A., LINDQVIST, M., & MAGNUSSON, T. (1957) · Nature · doi:10.1038/1801200a0 · Cited by 1,278
Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein
Giasson, B. I., Duda, J. E., Quinn, S. M., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2002) · Neuron · doi:10.1016/s0896-6273(02)00682-7 · Cited by 1,266
Javitch, J. A., D'Amato, R. J., Strittmatter, S. M., & Snyder, S. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2173 · Cited by 1,263
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
Shin, J.-H., Ko, H. S., Kang, H., Lee, Y., Lee, Y.-I., Pletinkova, O., Troconso, J. C., Dawson, V. L., & Dawson, T. M. (2011) · Cell · doi:10.1016/j.cell.2011.02.010 · Cited by 953
McCormack, A. L., Thiruchelvam, M., Manning-Bog, A. B., Thiffault, C., Langston, J. W., Cory-Slechta, D. A., & Di Monte, D. A. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0507 · Cited by 838
Genetic Animal Models of Parkinson's Disease
Dawson, T. M., Ko, H. S., & Dawson, V. L. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.034 · Cited by 823
Sauer, H., & Oertel, W. H. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90605-x · Cited by 803
A highly reproducible rotenone model of Parkinson's disease
Cannon, J. R., Tapias, V., Na, H. M., Honick, A. S., Drolet, R. E., & Greenamyre, J. T. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.016 · Cited by 795
SCHWARTING, R., & HUSTON, J. (1996) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00040-8 · Cited by 737
Sherer, T. B., Kim, J.-H., Betarbet, R., & Greenamyre, J. T. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8072 · Cited by 708
THE OCCURRENCE, DISTRIBUTION AND PHYSIOLOGICAL ROLE OF CATECHOLAMINES IN THE NERVOUS SYSTEM
Carlsson, A. (1959) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07428-9 · Cited by 689
The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice
Manning-Bog, A. B., McCormack, A. L., Li, J., Uversky, V. N., Fink, A. L., & Di Monte, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100560200 · Cited by 684
The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living
Gorell, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L., & Richardson, R. J. (1998) · Neurology · doi:10.1212/wnl.50.5.1346 · Cited by 639
Animal models of Parkinson's disease
Betarbet, R., Sherer, T. B., & Greenamyre, J. T. (2002) · BioEssays · doi:10.1002/bies.10067 · Cited by 592
Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP
Dauer, W., Kholodilov, N., Vila, M., Trillat, A.-C., Goodchild, R., Larsen, K. E., Staal, R., Tieu, K., Schmitz, Y., Yuan, C. A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172514599 · Cited by 581
Self-citationMutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
Li, Y., Liu, W., Oo, T. F., Wang, L., Tang, Y., Jackson-Lewis, V., Zhou, C., Geghman, K., Bogdanov, M., Przedborski, S., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2349 · Cited by 536
Self-citationFornai, F., Schlüter, O. M., Lenzi, P., Gesi, M., Ruffoli, R., Ferrucci, M., Lazzeri, G., Busceti, C. L., Pontarelli, F., Battaglia, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409713102 · Cited by 526
Pan-Montojo, F., Anichtchik, O., Dening, Y., Knels, L., Pursche, S., Jung, R., Jackson, S., Gille, G., Spillantini, M. G., Reichmann, H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008762 · Cited by 524
Przedborski, S., Jackson‐Lewis, V., Naini, A. B., Jakowec, M., Petzinger, G., Miller, R., & Akram, M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00183.x · Cited by 507
Self-citationPrzedbroski, S., Leviver, M., Jiang, H., Ferreira, M., Jackson-Lewis, V., Donaldson, D., & Togasaki, D. M. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00066-r · Cited by 453
Self-citationParaquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss
Brooks, A. I., Chadwick, C. A., Gelbard, H. A., Cory-Slechta, D. A., & Federoff, H. J. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01192-5 · Cited by 424
Vila, M., Jackson-Lewis, V., Vukosavic, S., Djaldetti, R., Liberatore, G., Offen, D., Korsmeyer, S. J., & Przedborski, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051633998 · Cited by 372
Self-citationMechanisms of action of 6-hydroxydopamine
Sachs, C., & Jonsson, G. (1975) · Biochemical Pharmacology · doi:10.1016/0006-2952(75)90304-4 · Cited by 357
Schwarting, R. K. W., & Huston, J. P. (1996) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00015-9 · Cited by 344
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats
Höglinger, G. U., Féger, J., Prigent, A., Michel, P. P., Parain, K., Champy, P., Ruberg, M., Oertel, W. H., & Hirsch, E. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01533.x · Cited by 331
Thiruchelvam, M., Brockel, B. J., Richfield, E. K., Baggs, R. B., & Cory-Slechta, D. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02496-3 · Cited by 324
The 6-hydroxydopamine model: News from the past
Blandini, F., Armentero, M.-T., & Martignoni, E. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.04.015 · Cited by 311
Paraquat and Parkinson's disease
Berry, C., La Vecchia, C., & Nicotera, P. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.217 · Cited by 309
Bankiewicz, K. S., Oldfield, E. H., Chiueh, C. C., Doppman, J. L., Jacobowitz, D. M., & Kopin, I. J. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90431-5 · Cited by 308
MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons
Kowall, N. W., Hantraye, P., Brouillet, E., Beal, M. F., McKee, A. C., & Ferrante, R. J. (2000) · NeuroReport · doi:10.1097/00001756-200001170-00041 · Cited by 291
Subthalamotomy in parkinsonian monkeys Behavioural and biochemical analysis
Guridi, J., Herrero, M. T., Luquin, M. R., Guillén, J., Ruberg, M., Laguna, J., Vila, M., Javoy-Agid, F., Agid, Y., Hirsch, E., et al. (1996) · Brain · doi:10.1093/brain/119.5.1717 · Cited by 263
Inden, M., Kitamura, Y., Takeuchi, H., Yanagida, T., Takata, K., Kobayashi, Y., Taniguchi, T., Yoshimoto, K., Kaneko, M., Okuma, Y., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04440.x · Cited by 260
MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects.
Langston, J. W., Langston, E. B., & Irwin, I. (1984) · PubMed · Cited by 249
Lee, C. S., Sauer, H., & Björklund, A. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00571-4 · Cited by 248
Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine
Burke, W. J., Kumar, V. B., Pandey, N., Panneton, W. M., Gan, Q., Franko, M. W., O’Dell, M., Li, S. W., Pan, Y., Chung, H. D., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0303-9 · Cited by 243
A 6-hydroxydopamine-induced selective parkinsonian rat model
Perese, D. A., Ulman, J., Viola, J., Ewing, S. E., & Bankiewicz, K. S. (1989) · Brain Research · doi:10.1016/0006-8993(89)90597-0 · Cited by 241
ANDERSON, G., NOORIAN, A., TAYLOR, G., ANITHA, M., BERNHARD, D., SRINIVASAN, S., & GREENE, J. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.010 · Cited by 238
Absence of MPTP-Induced Neuronal Death in Mice Lacking the Dopamine Transporter
Bezard, E., Gross, C. E., Fournier, M.-C., Dovero, S., Bloch, B., & Jaber, M. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6995 · Cited by 230
Environmental antecedents of young‐onset Parkinson's disease
Butterfield, P. G., Valanis, B. G., Spencer, P. S., Lindeman, C. A., & Nutt, J. G. (1993) · Neurology · doi:10.1212/wnl.43.6.1150 · Cited by 229
Chiueh, C. C., Markey, S. P., Burns, R. S., Johannessen, J. N., Pert, A., & Kopin, I. J. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90221-8 · Cited by 224
Oxy-radical toxicity in catecholamine neurons.
Cohen, G. (1984) · PubMed · Cited by 222
Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3
Rappold, P. M., Cui, M., Chesser, A. S., Tibbett, J., Grima, J. C., Duan, L., Sen, N., Javitch, J. A., & Tieu, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115141108 · Cited by 209
Forno, L. S., DeLanney, L. E., Irwin, I., & Langston, J. W. (1993) · PubMed · Cited by 207
A mechanism of paraquat toxicity involving nitric oxide synthase
Day, B. J., Patel, M., Calavetta, L., Chang, L.-Y., & Stamler, J. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12760 · Cited by 206
Ferrante, R. J., Schulz, J. B., Kowall, N. W., & Beal, M. F. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00008-5 · Cited by 203
Przedborski, S., & Ischiropoulos, H. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.685 · Cited by 202
Self-citationCui, M., Aras, R., Christian, W. V., Rappold, P. M., Hatwar, M., Panza, J., Jackson-Lewis, V., Javitch, J. A., Ballatori, N., Przedborski, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900358106 · Cited by 202
Self-citationProtective Actions of the Vesicular Monoamine Transporter 2 (VMAT2) in Monoaminergic Neurons
Guillot, T. S., & Miller, G. W. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8059-y · Cited by 201
Tang, C. C., Poston, K. L., Dhawan, V., & Eidelberg, D. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4188-09.2010 · Cited by 200
Increased MPTP Neurotoxicity in Vesicular Monoamine Transporter 2 Heterozygote Knockout Mice
Gainetdinov, R. R., Fumagalli, F., Wang, Y., Jones, S. R., Levey, A. I., Miller, G. W., & Caron, M. G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70051973.x · Cited by 178
Serotonin and Parkinson's disease: On movement, mood, and madness
Fox, S. H., Chuang, R., & Brotchie, J. M. (2009) · Movement Disorders · doi:10.1002/mds.22473 · Cited by 175
Bezard, E., Imbert, C., Deloire, X., Bioulac, B., & Gross, C. E. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00531-3 · Cited by 165
A tale on animal models of Parkinson's disease
Bezard, E., & Przedborski, S. (2011) · Movement Disorders · doi:10.1002/mds.23696 · Cited by 159
Self-citationInden, M., Kitamura, Y., Abe, M., Tamaki, A., Takata, K., & Taniguchi, T. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.92 · Cited by 149
A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery
Mounayar, S., Boulet, S., Tandé, D., Jan, C., Pessiglione, M., Hirsch, É. C., Féger, J., Savasta, M., François, C., & Tremblay, L. (2007) · Brain · doi:10.1093/brain/awm208 · Cited by 145
Increased striatal dopamine turnover following acute administration of rotenone to mice
Thiffault, C., Langston, J. W., & Monte, D. A. D. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02960-7 · Cited by 143
Panneton, W. M., Kumar, V. B., Gan, Q., Burke, W. J., & Galvin, J. E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015251 · Cited by 137
Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys
Ovadia, A., Zhang, Z., & Gash, D. M. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02012-8 · Cited by 131
Dispensable role of Drosophila ortholog of LRRK2 kinase activity in survival of dopaminergic neurons
Wang, D., Tang, B., Zhao, G., Pan, Q., Xia, K., Bodmer, R., & Zhang, Z. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-3 · Cited by 122
Takeuchi, H., Yanagida, T., Inden, M., Takata, K., Kitamura, Y., Yamakawa, K., Sawada, H., Izumi, Y., Yamamoto, N., Kihara, T., et al. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21869 · Cited by 111
Hantraye, P., Varastet, M., Peschanski, M., RICHE, D., Césaro, P., Jc, W., & Mazière, M. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90295-q · Cited by 107
Neuroanatomical Study of the A11 Diencephalospinal Pathway in the Non-Human Primate
Barraud, Q., Obeid, I., Aubert, I., Barrière, G., Contamin, H., McGuire, S., Ravenscroft, P., Porras, G., Tison, F., Bézard, E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013306 · Cited by 102
No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism
Halliday, G. M., Herrero, M. T., Murphy, K., McCann, H., Ros‐Bernal, F., Barcia, C., Mori, H., Blesa, F. J., & Obeso, J. A. (2009) · Movement Disorders · doi:10.1002/mds.22481 · Cited by 99
Zigmond, M. J., Berger, T. W., Grace, A. A., & Stricker, E. M. (1989) · Molecular and Chemical Neuropathology · doi:10.1007/bf03159728 · Cited by 98
Guillot, T. S., Shepherd, K. R., Richardson, J. R., Wang, M. Z., Li, Y., Emson, P. C., & Miller, G. W. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05568.x · Cited by 93
Non-enzymatic Conversions of Dopamine to Norepinephrine and Trihydroxyphenethylamines1
Senoh, S., & Witkop, B. (1959) · Journal of the American Chemical Society · doi:10.1021/ja01532a028 · Cited by 93
Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration
Kachroo, A., Irizarry, M. C., & Schwarzschild, M. A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.02.007 · Cited by 88
Alam, M., Mayerhofer, A., & Schmidt, W. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.08.014 · Cited by 82
Blesa, J., Carlos Juri, C., Collantes, M., Peñuelas, I., Prieto, E., Iglesias, E., Martí-Climent, J. M., Arbizu, J., Zubieta, J. L., Rodríguez-Oroz, M. C., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.006 · Cited by 81
Self-citationIravani, M. M., Syed, E. C. J., Jackson, M. J., Johnston, L. C., Smith, L. A., & Jenner, P. G. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03915.x · Cited by 75
A Fetal Risk Factor for Parkinson’s Disease
Barlow, B. K., Richfield, E. K., Cory‐Slechta, D. A., & Thiruchelvam, M. J. (2004) · Developmental Neuroscience · doi:10.1159/000080707 · Cited by 74
Thomas, B., Mandir, A. S., West, N. C., Liu, Y., Andrabi, S. A., Stirling, W. L. H., Dawson, V. L., Dawson, T. M., & Lee, M. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016706 · Cited by 74
Maneb enhances MPTP neurotoxicity in mice.
Rn, T., Rogério, R., & Zanin, M. (1989) · PubMed · Cited by 73
Behavioral and neurochemical dynamics of neurotoxic meso-striatal dopamine lesions.
Schwarting, R. K. W., & Huston, J. P. (1997) · PubMed · Cited by 65
Enhancement of audiogenic seizure by 6-hydroxydopamine
Bourn, W. M., Chin, L., & Picchioni, A. L. (1972) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1972.tb08916.x · Cited by 58
Vezoli, J., Fifel, K., Leviel, V., Dehay, C., Kennedy, H., Cooper, H. M., Gronfier, C., & Procyk, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023952 · Cited by 57
Peng, J., Oo, M. L., & Andersen, J. K. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07036.x · Cited by 54
Value of genetic models in understanding the cause and mechanisms of Parkinson’s disease
Moore, D. J., & Dawson, T. M. (2008) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-008-0045-7 · Cited by 51
Annett, L. E., Torres, E. M., Clarke, D. J., Ishida, Y., Barker, R. A., Ridley, R. M., Baker, H. F., & Dunnett, S. B. (1997) · Cell Transplantation · doi:10.1016/s0963-6897(97)00079-1 · Cited by 48
Pessiglione, M., Guehl, D., Hirsch, É. C., Féger, J., & Tremblay, L. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2003.03088.x · Cited by 46
Canine myocardial beta-adrenergic, muscarinic receptor densities after denervation: a PET study.
Valette, H., Deleuze, P., Syrota, A., Delforge, J., Crouzel, C., Fuseau, C., & Loisance, D. Y. (1995) · PubMed · Cited by 35
Wu, Y., & Johnson, S. W. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.041 · Cited by 35
Pan-Montojo, F. J., & Funk, R. H. W. (2010) · Journal of Visualized Experiments · doi:10.3791/2123 · Cited by 33
Roeling, T. A. P., Docter, G. J., Voorn, P., et al. (1995) · Journal of Chemical Neuroanatomy · doi:10.1016/0891-0618(95)00072-0 · Cited by 29
Modeling Cognitive Deficits Associated with Parkinsonism in the Chronic-Low-Dose MPTP-Treated Monkey
Levin, E. D., & Buccafusco, J. J. (2006) · CRC Press eBooks · doi:10.1201/9781420004335-14 · Cited by 9
Chemical Cardiac Sympathetic Denervation Hampers Defibrillation in the Dog
Ruffy, R., & Leonard, M. (1997) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1997.tb00609.x · Cited by 8
Cited by
Oxidative Stress in Neurodegenerative Diseases
Simonian, N. A., & Coyle, J. T. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.000503 · Cited by 1,377
Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., Peddada, S. D., Factor, S. A., Molho, E., Zabetian, C. P., et al. (2017) · Movement Disorders · doi:10.1002/mds.26942 · Cited by 874
Oxidative Stress in Neurodegenerative Diseases
Niedzielska, E., Smaga, I., Gawlik, M., Moniczewski, A., Stankowicz, P., Pera, J., & Filip, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9337-5 · Cited by 800
Parkinson disease: from pathology to molecular disease mechanisms
Dexter, D. T., & Jenner, P. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.018 · Cited by 707
Inflammation in neurodegenerative diseases—An update
Amor, S., Peferoen, L. A. N., Vogel, D. Y. S., Breur, M., van der Valk, P., Baker, D., & van Noort, J. M. (2014) · Immunology · doi:10.1111/imm.12233 · Cited by 550
Metadata
- Authors
- Blesa, J., Phani, S., Jackson-Lewis, V., & Przedborski, S.
- Venue
- Journal of Biomedicine and Biotechnology
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-10
- ISSN
- 1110-7243 (ISSN-L)
- 1110-7251
- OpenAlex
- W2050865611
- Cited by
- 505
- References
- 103
- FWCI
- 29.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.